StockTipsArenaBeta

BUY Syngene International Limited — Goldman Sachs

BUYSyngene International Limited
Syngene International share price target & all analyst calls

byGoldman SachsHorizon: NA (inferred 1 year)1 Sept 2026via Zee Business (Live)

Entry₹402Inferred
Target₹450
Total upside +11.94%
Stop lossNot given
CMP₹366.85Just now
Active-8.74%+22.67%upside left 10 mo left
Follow Goldman Sachs for new calls(100% target hit, 31 closed calls)Get alertsWatch SYNGENE for new buy/sell callsGet alertsSee 1 other Long-term call on SYNGENESee 268 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 5:02 pm IST
4 supporting10 neutral4 opposing
Supports the BUY call (4)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·30 Jul · 3mo ago

Neutral / worth noting (10)

Q2 FY27 results scheduled — board meets 27 Oct 2026

BSE · Board Meeting·In 4 days

(opens in new tab)
Weighs against the BUY call (4)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·22 Oct · yesterday

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Syngene International

All analyst calls on Syngene International

More from Goldman Sachs

Every call and its outcome